This study demonstrated that edaravone attenuated AngII-induced AAA and atherosclerosis in apoE−/− mice, associated with a reduction in oxidative stress and inflammation in the aorta, a decrease in elastin degradation of the medial layer, and less accumulation of inflammatory cells in the vascular lesion. The gene discussed is AGT; the disease is triple-A syndrome.